Purpose Pharmacokinetic considerations in patients who have undergone Roux-en-Y gastric bypass (RYGB) are explored. Summary The prevalence of obesity, especially morbid obesity, has dramatically ...

Pharmacokinetic Considerations in Roux-en-Y Gastric Bypass Patients April Smith; Brian Henriksen; Andrew Cohen Disclosures Am J Health Syst Pharm. 2011;68 (23):2241-2247.

Bariatric surgery is a medical procedure that alters the digestive system to help individuals with obesity lose weight by ...

Different types of weight loss surgery can be effective for long-term weight management in people with severe obesity or who ...

Amylyx reports strong Phase 2b trial data for avexitide, showing 64% fewer hypoglycemic events in patients with post-bariatric hypoglycemia.

Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) is one of the best low priced pharma stocks to buy now. On July 13, Amylyx Pharmaceuticals announced new exploratory analyses from its Phase 2 PREVENT and ...

We looked for studies that compared the uncut Roux-en-Y reconstruction with other types of reconstruction (Billroth I, Billroth II, and regular Roux-en-Y) after a distal gastrectomy for stomach cancer ...